
We aimed to determine the effect of the dipeptidyl peptidase‐4 inhibitor linagliptin on postprandial glomerular hyperfiltration compared with the sulphonylurea glimepiride in adults with type 2 diabetes (T2D). Compared with glimepiride, linagliptin increased the postprandial filtration fraction and estimated glomerular hydraulic pressure , and tended to increase GFR and estimated efferent renal arteriolar resistance from baseline to week 8. No differences in FE were noted. In contrast to our hypothesis, compared with glimepiride, linagliptin does not reduce postprandial hyperfiltration, yet appears to increase FF after meal ingestion by increasing blood pressure or RE.
Like
Save
Share